nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B1—breast cancer	0.242	0.697	CbGaD
Fexofenadine—Loperamide—Toremifene—breast cancer	0.106	0.486	CrCrCtD
Fexofenadine—Loperamide—Tamoxifen—breast cancer	0.0665	0.305	CrCrCtD
Fexofenadine—CYP2D6—breast cancer	0.0615	0.177	CbGaD
Fexofenadine—SLCO1A2—Chlorambucil—breast cancer	0.0574	0.2	CbGbCtD
Fexofenadine—Methadone—Tamoxifen—breast cancer	0.0457	0.209	CrCrCtD
Fexofenadine—ABCB1—breast cancer	0.0439	0.126	CbGaD
Fexofenadine—SLCO1B3—Paclitaxel—breast cancer	0.0319	0.111	CbGbCtD
Fexofenadine—SLCO1B3—Docetaxel—breast cancer	0.0231	0.0804	CbGbCtD
Fexofenadine—ABCB1—Toremifene—breast cancer	0.0187	0.0653	CbGbCtD
Fexofenadine—SLCO1B1—Irinotecan—breast cancer	0.0183	0.0639	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—breast cancer	0.0167	0.0581	CbGbCtD
Fexofenadine—CYP2D6—Idarubicin—breast cancer	0.0146	0.051	CbGbCtD
Fexofenadine—ABCB1—Lapatinib—breast cancer	0.0137	0.0476	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—breast cancer	0.0103	0.0359	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—breast cancer	0.00971	0.0338	CbGbCtD
Fexofenadine—ABCB1—Vinorelbine—breast cancer	0.00758	0.0264	CbGbCtD
Fexofenadine—CYP2D6—Vinorelbine—breast cancer	0.00714	0.0249	CbGbCtD
Fexofenadine—ABCB1—Tamoxifen—breast cancer	0.00684	0.0238	CbGbCtD
Fexofenadine—ABCB1—Mitoxantrone—breast cancer	0.00667	0.0233	CbGbCtD
Fexofenadine—CYP2D6—Tamoxifen—breast cancer	0.00645	0.0225	CbGbCtD
Fexofenadine—ABCB1—Gemcitabine—breast cancer	0.00589	0.0205	CbGbCtD
Fexofenadine—ABCB1—Paclitaxel—breast cancer	0.00532	0.0186	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—breast cancer	0.00525	0.0183	CbGbCtD
Fexofenadine—ABCB1—Vinblastine—breast cancer	0.00467	0.0163	CbGbCtD
Fexofenadine—CYP2D6—Vinblastine—breast cancer	0.0044	0.0153	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—breast cancer	0.00385	0.0134	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—breast cancer	0.00287	0.01	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—breast cancer	0.00278	0.00969	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—breast cancer	0.0027	0.00942	CbGbCtD
Fexofenadine—SLCO1B1—mammary gland—breast cancer	0.000613	0.0941	CbGeAlD
Fexofenadine—SLCO2B1—mammary gland—breast cancer	0.000542	0.0832	CbGeAlD
Fexofenadine—SLCO1B3—pituitary gland—breast cancer	0.000479	0.0735	CbGeAlD
Fexofenadine—SLCO1B3—endocrine gland—breast cancer	0.000371	0.057	CbGeAlD
Fexofenadine—SLCO1B1—female reproductive system—breast cancer	0.000254	0.0389	CbGeAlD
Fexofenadine—HRH1—nipple—breast cancer	0.000253	0.0388	CbGeAlD
Fexofenadine—SLCO2B1—uterus—breast cancer	0.00025	0.0383	CbGeAlD
Fexofenadine—SLCO2B1—adipose tissue—breast cancer	0.000244	0.0375	CbGeAlD
Fexofenadine—SLCO2B1—female reproductive system—breast cancer	0.000224	0.0344	CbGeAlD
Fexofenadine—SLCO2B1—adrenal gland—breast cancer	0.000219	0.0336	CbGeAlD
Fexofenadine—SLCO1B1—endocrine gland—breast cancer	0.000215	0.0329	CbGeAlD
Fexofenadine—Lomitapide—CYP3A4—breast cancer	0.000214	0.18	CrCbGaD
Fexofenadine—SLCO2B1—female gonad—breast cancer	0.000204	0.0313	CbGeAlD
Fexofenadine—SLCO2B1—endocrine gland—breast cancer	0.00019	0.0291	CbGeAlD
Fexofenadine—Lomitapide—ABCB1—breast cancer	0.000178	0.15	CrCbGaD
Fexofenadine—SLCO1A2—endocrine gland—breast cancer	0.000175	0.0268	CbGeAlD
Fexofenadine—HRH1—epithelium—breast cancer	0.00017	0.0261	CbGeAlD
Fexofenadine—HRH1—endometrium—breast cancer	0.000153	0.0234	CbGeAlD
Fexofenadine—HRH1—adipose tissue—breast cancer	0.000137	0.0211	CbGeAlD
Fexofenadine—SLCO2B1—lymph node—breast cancer	0.000131	0.0201	CbGeAlD
Fexofenadine—HRH1—female reproductive system—breast cancer	0.000126	0.0194	CbGeAlD
Fexofenadine—HRH1—adrenal gland—breast cancer	0.000123	0.0189	CbGeAlD
Fexofenadine—HRH1—female gonad—breast cancer	0.000115	0.0176	CbGeAlD
Fexofenadine—ABCB1—embryo—breast cancer	0.000114	0.0175	CbGeAlD
Fexofenadine—HRH1—endocrine gland—breast cancer	0.000107	0.0164	CbGeAlD
Fexofenadine—CYP2D6—female reproductive system—breast cancer	9.62e-05	0.0148	CbGeAlD
Fexofenadine—Darifenacin—CYP2D6—breast cancer	9.61e-05	0.0807	CrCbGaD
Fexofenadine—ABCB1—epithelium—breast cancer	9.31e-05	0.0143	CbGeAlD
Fexofenadine—CYP2D6—female gonad—breast cancer	8.75e-05	0.0134	CbGeAlD
Fexofenadine—ABCB1—endometrium—breast cancer	8.35e-05	0.0128	CbGeAlD
Fexofenadine—Darifenacin—CYP3A4—breast cancer	8.25e-05	0.0692	CrCbGaD
Fexofenadine—CYP2D6—endocrine gland—breast cancer	8.14e-05	0.0125	CbGeAlD
Fexofenadine—Methadone—CYP19A1—breast cancer	7.74e-05	0.065	CrCbGaD
Fexofenadine—ABCB1—uterus—breast cancer	7.69e-05	0.0118	CbGeAlD
Fexofenadine—ABCB1—pituitary gland—breast cancer	7.56e-05	0.0116	CbGeAlD
Fexofenadine—ABCB1—adipose tissue—breast cancer	7.53e-05	0.0115	CbGeAlD
Fexofenadine—HRH1—lymph node—breast cancer	7.39e-05	0.0113	CbGeAlD
Fexofenadine—Pimozide—CYP2D6—breast cancer	7.13e-05	0.0598	CrCbGaD
Fexofenadine—Pain—Fluorouracil—breast cancer	6.97e-05	0.000763	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Irinotecan—breast cancer	6.96e-05	0.000762	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Mitoxantrone—breast cancer	6.96e-05	0.000762	CcSEcCtD
Fexofenadine—Anaphylactic shock—Paclitaxel—breast cancer	6.94e-05	0.00076	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Methotrexate—breast cancer	6.93e-05	0.000759	CcSEcCtD
Fexofenadine—ABCB1—female reproductive system—breast cancer	6.92e-05	0.0106	CbGeAlD
Fexofenadine—Infection—Paclitaxel—breast cancer	6.89e-05	0.000755	CcSEcCtD
Fexofenadine—Flatulence—Capecitabine—breast cancer	6.87e-05	0.000753	CcSEcCtD
Fexofenadine—Nausea—Goserelin—breast cancer	6.84e-05	0.000749	CcSEcCtD
Fexofenadine—Dizziness—Vinorelbine—breast cancer	6.82e-05	0.000747	CcSEcCtD
Fexofenadine—Tachycardia—Paclitaxel—breast cancer	6.77e-05	0.000742	CcSEcCtD
Fexofenadine—Urticaria—Mitoxantrone—breast cancer	6.76e-05	0.00074	CcSEcCtD
Fexofenadine—ABCB1—adrenal gland—breast cancer	6.75e-05	0.0104	CbGeAlD
Fexofenadine—Back pain—Capecitabine—breast cancer	6.75e-05	0.000739	CcSEcCtD
Fexofenadine—Diarrhoea—Thiotepa—breast cancer	6.74e-05	0.000738	CcSEcCtD
Fexofenadine—Abdominal pain—Mitoxantrone—breast cancer	6.72e-05	0.000737	CcSEcCtD
Fexofenadine—Abdominal pain—Irinotecan—breast cancer	6.72e-05	0.000737	CcSEcCtD
Fexofenadine—Body temperature increased—Irinotecan—breast cancer	6.72e-05	0.000737	CcSEcCtD
Fexofenadine—Body temperature increased—Mitoxantrone—breast cancer	6.72e-05	0.000737	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—breast cancer	6.68e-05	0.000731	CcSEcCtD
Fexofenadine—Drowsiness—Methotrexate—breast cancer	6.64e-05	0.000728	CcSEcCtD
Fexofenadine—Vision blurred—Capecitabine—breast cancer	6.57e-05	0.00072	CcSEcCtD
Fexofenadine—Vomiting—Vinorelbine—breast cancer	6.56e-05	0.000718	CcSEcCtD
Fexofenadine—Body temperature increased—Gemcitabine—breast cancer	6.55e-05	0.000718	CcSEcCtD
Fexofenadine—ABCB1—bone marrow—breast cancer	6.53e-05	0.01	CbGeAlD
Fexofenadine—Dizziness—Thiotepa—breast cancer	6.51e-05	0.000714	CcSEcCtD
Fexofenadine—Rash—Vinorelbine—breast cancer	6.5e-05	0.000712	CcSEcCtD
Fexofenadine—Dermatitis—Vinorelbine—breast cancer	6.5e-05	0.000712	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—breast cancer	6.48e-05	0.00071	CcSEcCtD
Fexofenadine—Urticaria—Fluorouracil—breast cancer	6.47e-05	0.000709	CcSEcCtD
Fexofenadine—Headache—Vinorelbine—breast cancer	6.46e-05	0.000708	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—breast cancer	6.44e-05	0.000706	CcSEcCtD
Fexofenadine—Body temperature increased—Fluorouracil—breast cancer	6.44e-05	0.000706	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—breast cancer	6.37e-05	0.000697	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.32e-05	0.000692	CcSEcCtD
Fexofenadine—ABCB1—female gonad—breast cancer	6.29e-05	0.00966	CbGeAlD
Fexofenadine—Cough—Docetaxel—breast cancer	6.29e-05	0.000689	CcSEcCtD
Fexofenadine—Insomnia—Paclitaxel—breast cancer	6.27e-05	0.000687	CcSEcCtD
Fexofenadine—Epistaxis—Methotrexate—breast cancer	6.27e-05	0.000687	CcSEcCtD
Fexofenadine—Hypersensitivity—Mitoxantrone—breast cancer	6.27e-05	0.000687	CcSEcCtD
Fexofenadine—Hypersensitivity—Irinotecan—breast cancer	6.27e-05	0.000687	CcSEcCtD
Fexofenadine—Vomiting—Thiotepa—breast cancer	6.26e-05	0.000686	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—breast cancer	6.22e-05	0.000681	CcSEcCtD
Fexofenadine—Rash—Thiotepa—breast cancer	6.21e-05	0.00068	CcSEcCtD
Fexofenadine—Dermatitis—Thiotepa—breast cancer	6.2e-05	0.00068	CcSEcCtD
Fexofenadine—Dyspnoea—Paclitaxel—breast cancer	6.18e-05	0.000678	CcSEcCtD
Fexofenadine—Headache—Thiotepa—breast cancer	6.17e-05	0.000676	CcSEcCtD
Fexofenadine—Somnolence—Paclitaxel—breast cancer	6.17e-05	0.000676	CcSEcCtD
Fexofenadine—Palpitations—Capecitabine—breast cancer	6.16e-05	0.000675	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—breast cancer	6.13e-05	0.000672	CcSEcCtD
Fexofenadine—Nausea—Vinorelbine—breast cancer	6.13e-05	0.000671	CcSEcCtD
Fexofenadine—Pimozide—CYP3A4—breast cancer	6.11e-05	0.0513	CrCbGaD
Fexofenadine—Dyspepsia—Paclitaxel—breast cancer	6.11e-05	0.000669	CcSEcCtD
Fexofenadine—Asthenia—Mitoxantrone—breast cancer	6.1e-05	0.000669	CcSEcCtD
Fexofenadine—Asthenia—Irinotecan—breast cancer	6.1e-05	0.000669	CcSEcCtD
Fexofenadine—Cough—Capecitabine—breast cancer	6.09e-05	0.000667	CcSEcCtD
Fexofenadine—Hypersensitivity—Fluorouracil—breast cancer	6e-05	0.000658	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—breast cancer	6e-05	0.000657	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—breast cancer	6e-05	0.000657	CcSEcCtD
Fexofenadine—Fatigue—Paclitaxel—breast cancer	5.98e-05	0.000655	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—breast cancer	5.96e-05	0.000653	CcSEcCtD
Fexofenadine—Loperamide—CYP2D6—breast cancer	5.95e-05	0.05	CrCbGaD
Fexofenadine—Asthenia—Gemcitabine—breast cancer	5.94e-05	0.000651	CcSEcCtD
Fexofenadine—Myalgia—Capecitabine—breast cancer	5.94e-05	0.000651	CcSEcCtD
Fexofenadine—Pain—Paclitaxel—breast cancer	5.93e-05	0.00065	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—breast cancer	5.88e-05	0.000644	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—breast cancer	5.87e-05	0.000643	CcSEcCtD
Fexofenadine—Pruritus—Gemcitabine—breast cancer	5.86e-05	0.000642	CcSEcCtD
Fexofenadine—ABCB1—endocrine gland—breast cancer	5.85e-05	0.00898	CbGeAlD
Fexofenadine—Nausea—Thiotepa—breast cancer	5.85e-05	0.000641	CcSEcCtD
Fexofenadine—Infection—Docetaxel—breast cancer	5.84e-05	0.00064	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—breast cancer	5.83e-05	0.000639	CcSEcCtD
Fexofenadine—Diarrhoea—Mitoxantrone—breast cancer	5.82e-05	0.000638	CcSEcCtD
Fexofenadine—Diarrhoea—Irinotecan—breast cancer	5.82e-05	0.000638	CcSEcCtD
Fexofenadine—Dry mouth—Capecitabine—breast cancer	5.81e-05	0.000636	CcSEcCtD
Fexofenadine—Pruritus—Fluorouracil—breast cancer	5.76e-05	0.000631	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—breast cancer	5.75e-05	0.00063	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—breast cancer	5.74e-05	0.000629	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Paclitaxel—breast cancer	5.67e-05	0.000621	CcSEcCtD
Fexofenadine—Diarrhoea—Gemcitabine—breast cancer	5.67e-05	0.000621	CcSEcCtD
Fexofenadine—Infection—Capecitabine—breast cancer	5.66e-05	0.00062	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—breast cancer	5.62e-05	0.000616	CcSEcCtD
Fexofenadine—Diarrhoea—Fluorouracil—breast cancer	5.57e-05	0.000611	CcSEcCtD
Fexofenadine—Tachycardia—Capecitabine—breast cancer	5.56e-05	0.000609	CcSEcCtD
Fexofenadine—Urticaria—Paclitaxel—breast cancer	5.51e-05	0.000604	CcSEcCtD
Fexofenadine—Body temperature increased—Paclitaxel—breast cancer	5.48e-05	0.000601	CcSEcCtD
Fexofenadine—Abdominal pain—Paclitaxel—breast cancer	5.48e-05	0.000601	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—breast cancer	5.43e-05	0.000595	CcSEcCtD
Fexofenadine—Vomiting—Mitoxantrone—breast cancer	5.41e-05	0.000592	CcSEcCtD
Fexofenadine—Vomiting—Irinotecan—breast cancer	5.41e-05	0.000592	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—breast cancer	5.4e-05	0.000591	CcSEcCtD
Fexofenadine—Dizziness—Fluorouracil—breast cancer	5.39e-05	0.00059	CcSEcCtD
Fexofenadine—Rash—Mitoxantrone—breast cancer	5.36e-05	0.000588	CcSEcCtD
Fexofenadine—Rash—Irinotecan—breast cancer	5.36e-05	0.000588	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—breast cancer	5.36e-05	0.000587	CcSEcCtD
Fexofenadine—Dermatitis—Mitoxantrone—breast cancer	5.36e-05	0.000587	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.36e-05	0.000587	CcSEcCtD
Fexofenadine—Headache—Irinotecan—breast cancer	5.33e-05	0.000584	CcSEcCtD
Fexofenadine—Headache—Mitoxantrone—breast cancer	5.33e-05	0.000584	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—breast cancer	5.32e-05	0.000583	CcSEcCtD
Fexofenadine—Fentanyl—CYP3A4—breast cancer	5.3e-05	0.0445	CrCbGaD
Fexofenadine—Vomiting—Gemcitabine—breast cancer	5.27e-05	0.000577	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—breast cancer	5.24e-05	0.000574	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—breast cancer	5.23e-05	0.000573	CcSEcCtD
Fexofenadine—Rash—Gemcitabine—breast cancer	5.22e-05	0.000572	CcSEcCtD
Fexofenadine—Dermatitis—Gemcitabine—breast cancer	5.22e-05	0.000572	CcSEcCtD
Fexofenadine—Headache—Gemcitabine—breast cancer	5.19e-05	0.000569	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.19e-05	0.000568	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—breast cancer	5.18e-05	0.000568	CcSEcCtD
Fexofenadine—Vomiting—Fluorouracil—breast cancer	5.18e-05	0.000567	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—breast cancer	5.18e-05	0.000567	CcSEcCtD
Fexofenadine—Insomnia—Capecitabine—breast cancer	5.15e-05	0.000564	CcSEcCtD
Fexofenadine—Rash—Fluorouracil—breast cancer	5.14e-05	0.000563	CcSEcCtD
Fexofenadine—Dermatitis—Fluorouracil—breast cancer	5.13e-05	0.000562	CcSEcCtD
Fexofenadine—Hypersensitivity—Paclitaxel—breast cancer	5.11e-05	0.00056	CcSEcCtD
Fexofenadine—Loperamide—CYP3A4—breast cancer	5.1e-05	0.0429	CrCbGaD
Fexofenadine—Headache—Fluorouracil—breast cancer	5.1e-05	0.000559	CcSEcCtD
Fexofenadine—Pimozide—ABCB1—breast cancer	5.09e-05	0.0427	CrCbGaD
Fexofenadine—Dyspnoea—Capecitabine—breast cancer	5.08e-05	0.000556	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—breast cancer	5.07e-05	0.000555	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—breast cancer	5.05e-05	0.000553	CcSEcCtD
Fexofenadine—Nausea—Mitoxantrone—breast cancer	5.05e-05	0.000553	CcSEcCtD
Fexofenadine—Pain—Docetaxel—breast cancer	5.03e-05	0.000551	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—breast cancer	5.02e-05	0.00055	CcSEcCtD
Fexofenadine—Dyspepsia—Capecitabine—breast cancer	5.01e-05	0.000549	CcSEcCtD
Fexofenadine—Asthenia—Paclitaxel—breast cancer	4.98e-05	0.000545	CcSEcCtD
Fexofenadine—Nausea—Gemcitabine—breast cancer	4.92e-05	0.000539	CcSEcCtD
Fexofenadine—Fatigue—Capecitabine—breast cancer	4.91e-05	0.000538	CcSEcCtD
Fexofenadine—Pruritus—Paclitaxel—breast cancer	4.91e-05	0.000538	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—breast cancer	4.89e-05	0.000536	CcSEcCtD
Fexofenadine—Pain—Capecitabine—breast cancer	4.87e-05	0.000533	CcSEcCtD
Fexofenadine—Nausea—Fluorouracil—breast cancer	4.84e-05	0.00053	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—breast cancer	4.81e-05	0.000527	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—breast cancer	4.79e-05	0.000525	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—breast cancer	4.79e-05	0.000525	CcSEcCtD
Fexofenadine—Tension—Epirubicin—breast cancer	4.77e-05	0.000522	CcSEcCtD
Fexofenadine—Diarrhoea—Paclitaxel—breast cancer	4.75e-05	0.00052	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—breast cancer	4.72e-05	0.000517	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—breast cancer	4.7e-05	0.000515	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Capecitabine—breast cancer	4.66e-05	0.00051	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—breast cancer	4.65e-05	0.000509	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—breast cancer	4.65e-05	0.000509	CcSEcCtD
Fexofenadine—Dizziness—Paclitaxel—breast cancer	4.59e-05	0.000503	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—breast cancer	4.58e-05	0.000502	CcSEcCtD
Fexofenadine—Cough—Methotrexate—breast cancer	4.53e-05	0.000496	CcSEcCtD
Fexofenadine—Urticaria—Capecitabine—breast cancer	4.52e-05	0.000495	CcSEcCtD
Fexofenadine—Abdominal pain—Capecitabine—breast cancer	4.5e-05	0.000493	CcSEcCtD
Fexofenadine—Body temperature increased—Capecitabine—breast cancer	4.5e-05	0.000493	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—breast cancer	4.47e-05	0.000489	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—breast cancer	4.43e-05	0.000485	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—breast cancer	4.42e-05	0.000484	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—breast cancer	4.41e-05	0.000483	CcSEcCtD
Fexofenadine—Fentanyl—ABCB1—breast cancer	4.41e-05	0.037	CrCbGaD
Fexofenadine—Vomiting—Paclitaxel—breast cancer	4.41e-05	0.000483	CcSEcCtD
Fexofenadine—Rash—Paclitaxel—breast cancer	4.37e-05	0.000479	CcSEcCtD
Fexofenadine—Dermatitis—Paclitaxel—breast cancer	4.37e-05	0.000479	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—breast cancer	4.37e-05	0.000478	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—breast cancer	4.35e-05	0.000476	CcSEcCtD
Fexofenadine—Headache—Paclitaxel—breast cancer	4.35e-05	0.000476	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—breast cancer	4.33e-05	0.000475	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—breast cancer	4.29e-05	0.00047	CcSEcCtD
Fexofenadine—Loperamide—ABCB1—breast cancer	4.25e-05	0.0357	CrCbGaD
Fexofenadine—Cough—Epirubicin—breast cancer	4.24e-05	0.000465	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—breast cancer	4.24e-05	0.000464	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—breast cancer	4.24e-05	0.000464	CcSEcCtD
Fexofenadine—Methadone—CYP2D6—breast cancer	4.24e-05	0.0356	CrCbGaD
Fexofenadine—Asthenia—Docetaxel—breast cancer	4.22e-05	0.000462	CcSEcCtD
Fexofenadine—Infection—Methotrexate—breast cancer	4.21e-05	0.000461	CcSEcCtD
Fexofenadine—Hypersensitivity—Capecitabine—breast cancer	4.19e-05	0.000459	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—breast cancer	4.16e-05	0.000456	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—breast cancer	4.14e-05	0.000453	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—breast cancer	4.13e-05	0.000453	CcSEcCtD
Fexofenadine—Nausea—Paclitaxel—breast cancer	4.12e-05	0.000451	CcSEcCtD
Fexofenadine—Asthenia—Capecitabine—breast cancer	4.08e-05	0.000447	CcSEcCtD
Fexofenadine—ABCB1—lymph node—breast cancer	4.05e-05	0.00621	CbGeAlD
Fexofenadine—Dry mouth—Epirubicin—breast cancer	4.05e-05	0.000443	CcSEcCtD
Fexofenadine—Pruritus—Capecitabine—breast cancer	4.03e-05	0.000441	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—breast cancer	4.02e-05	0.000441	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—breast cancer	3.97e-05	0.000435	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—breast cancer	3.97e-05	0.000434	CcSEcCtD
Fexofenadine—Infection—Epirubicin—breast cancer	3.94e-05	0.000432	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—breast cancer	3.92e-05	0.00043	CcSEcCtD
Fexofenadine—Diarrhoea—Capecitabine—breast cancer	3.9e-05	0.000427	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—breast cancer	3.89e-05	0.000426	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—breast cancer	3.87e-05	0.000424	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.86e-05	0.000423	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—breast cancer	3.83e-05	0.00042	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—breast cancer	3.83e-05	0.000419	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—breast cancer	3.78e-05	0.000414	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—breast cancer	3.77e-05	0.000413	CcSEcCtD
Fexofenadine—Dizziness—Capecitabine—breast cancer	3.76e-05	0.000412	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—breast cancer	3.74e-05	0.00041	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—breast cancer	3.74e-05	0.00041	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—breast cancer	3.73e-05	0.000409	CcSEcCtD
Fexofenadine—Rash—Docetaxel—breast cancer	3.71e-05	0.000406	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—breast cancer	3.7e-05	0.000406	CcSEcCtD
Fexofenadine—Headache—Docetaxel—breast cancer	3.68e-05	0.000404	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—breast cancer	3.67e-05	0.000402	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—breast cancer	3.65e-05	0.0004	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—breast cancer	3.65e-05	0.000399	CcSEcCtD
Fexofenadine—Methadone—CYP3A4—breast cancer	3.63e-05	0.0305	CrCbGaD
Fexofenadine—Pain—Methotrexate—breast cancer	3.62e-05	0.000397	CcSEcCtD
Fexofenadine—Vomiting—Capecitabine—breast cancer	3.62e-05	0.000397	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.61e-05	0.000396	CcSEcCtD
Fexofenadine—Rash—Capecitabine—breast cancer	3.59e-05	0.000393	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—breast cancer	3.59e-05	0.000393	CcSEcCtD
Fexofenadine—Dermatitis—Capecitabine—breast cancer	3.59e-05	0.000393	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—breast cancer	3.58e-05	0.000392	CcSEcCtD
Fexofenadine—Headache—Capecitabine—breast cancer	3.57e-05	0.000391	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—breast cancer	3.54e-05	0.000387	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—breast cancer	3.53e-05	0.000386	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—breast cancer	3.49e-05	0.000383	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—breast cancer	3.49e-05	0.000382	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—breast cancer	3.47e-05	0.00038	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—breast cancer	3.42e-05	0.000375	CcSEcCtD
Fexofenadine—Pain—Epirubicin—breast cancer	3.39e-05	0.000372	CcSEcCtD
Fexofenadine—Nausea—Capecitabine—breast cancer	3.38e-05	0.00037	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—breast cancer	3.37e-05	0.000369	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—breast cancer	3.35e-05	0.000367	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—breast cancer	3.35e-05	0.000367	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.34e-05	0.000366	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—breast cancer	3.32e-05	0.000364	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—breast cancer	3.27e-05	0.000358	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—breast cancer	3.26e-05	0.000357	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—breast cancer	3.24e-05	0.000355	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—breast cancer	3.23e-05	0.000354	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—breast cancer	3.16e-05	0.000347	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—breast cancer	3.15e-05	0.000345	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—breast cancer	3.14e-05	0.000344	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—breast cancer	3.14e-05	0.000343	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—breast cancer	3.14e-05	0.000343	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—breast cancer	3.12e-05	0.000342	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—breast cancer	3.04e-05	0.000333	CcSEcCtD
Fexofenadine—Methadone—ABCB1—breast cancer	3.03e-05	0.0254	CrCbGaD
Fexofenadine—Gastrointestinal pain—Doxorubicin—breast cancer	3e-05	0.000329	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—breast cancer	3e-05	0.000328	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—breast cancer	2.92e-05	0.00032	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—breast cancer	2.92e-05	0.000319	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—breast cancer	2.9e-05	0.000318	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—breast cancer	2.9e-05	0.000318	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—breast cancer	2.9e-05	0.000318	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—breast cancer	2.85e-05	0.000312	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—breast cancer	2.81e-05	0.000307	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—breast cancer	2.8e-05	0.000307	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—breast cancer	2.71e-05	0.000297	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—breast cancer	2.7e-05	0.000296	CcSEcCtD
Fexofenadine—Vomiting—Methotrexate—breast cancer	2.69e-05	0.000295	CcSEcCtD
Fexofenadine—Rash—Methotrexate—breast cancer	2.67e-05	0.000293	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—breast cancer	2.67e-05	0.000292	CcSEcCtD
Fexofenadine—Headache—Methotrexate—breast cancer	2.65e-05	0.000291	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—breast cancer	2.63e-05	0.000288	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—breast cancer	2.62e-05	0.000287	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—breast cancer	2.6e-05	0.000284	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—breast cancer	2.52e-05	0.000276	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—breast cancer	2.52e-05	0.000276	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—breast cancer	2.51e-05	0.000275	CcSEcCtD
Fexofenadine—Rash—Epirubicin—breast cancer	2.5e-05	0.000274	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—breast cancer	2.5e-05	0.000274	CcSEcCtD
Fexofenadine—Headache—Epirubicin—breast cancer	2.48e-05	0.000272	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—breast cancer	2.43e-05	0.000266	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—breast cancer	2.36e-05	0.000258	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—breast cancer	2.33e-05	0.000256	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—breast cancer	2.31e-05	0.000253	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—breast cancer	2.31e-05	0.000253	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—breast cancer	2.3e-05	0.000252	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—breast cancer	2.18e-05	0.000239	CcSEcCtD
Fexofenadine—SLCO1B1—Metabolism—GPX1—breast cancer	4.96e-06	0.000103	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NAT2—breast cancer	4.94e-06	0.000102	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CAV1—breast cancer	4.94e-06	0.000102	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CYP1A1—breast cancer	4.91e-06	0.000102	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ERCC2—breast cancer	4.87e-06	0.000101	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.83e-06	0.0001	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FLT1—breast cancer	4.8e-06	9.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF3—breast cancer	4.78e-06	9.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SQSTM1—breast cancer	4.78e-06	9.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	4.76e-06	9.84e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—NOS3—breast cancer	4.75e-06	9.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAG1—breast cancer	4.72e-06	9.76e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.72e-06	9.75e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PARP1—breast cancer	4.7e-06	9.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH3—breast cancer	4.7e-06	9.72e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.68e-06	9.67e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CALCA—breast cancer	4.64e-06	9.6e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—DPYD—breast cancer	4.6e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MED12—breast cancer	4.6e-06	9.52e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RPS6—breast cancer	4.59e-06	9.49e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—breast cancer	4.58e-06	9.46e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF4—breast cancer	4.55e-06	9.42e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR4—breast cancer	4.54e-06	9.38e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL12—breast cancer	4.54e-06	9.38e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALDOA—breast cancer	4.53e-06	9.37e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—breast cancer	4.5e-06	9.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PAK1—breast cancer	4.45e-06	9.21e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA3—breast cancer	4.4e-06	9.1e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—breast cancer	4.38e-06	9.07e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TCF7L2—breast cancer	4.37e-06	9.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A2—breast cancer	4.37e-06	9.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT2—breast cancer	4.35e-06	9e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTGS2—breast cancer	4.34e-06	8.98e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MED12—breast cancer	4.34e-06	8.97e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—DPYD—breast cancer	4.34e-06	8.97e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—breast cancer	4.32e-06	8.94e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCG2—breast cancer	4.28e-06	8.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CPT1A—breast cancer	4.28e-06	8.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTR—breast cancer	4.28e-06	8.85e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALDOA—breast cancer	4.27e-06	8.83e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CAV1—breast cancer	4.22e-06	8.73e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH2—breast cancer	4.22e-06	8.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HSP90AA1—breast cancer	4.22e-06	8.72e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HPGDS—breast cancer	4.2e-06	8.68e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	4.18e-06	8.65e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HBA1—breast cancer	4.17e-06	8.62e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA3—breast cancer	4.14e-06	8.57e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A2—breast cancer	4.11e-06	8.51e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AGTR1—breast cancer	4.1e-06	8.48e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRL—breast cancer	4.1e-06	8.48e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—breast cancer	4.07e-06	8.42e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ACHE—breast cancer	4.07e-06	8.42e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ADAM10—breast cancer	4.04e-06	8.36e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STK11—breast cancer	4.04e-06	8.36e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.03e-06	8.34e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG2—breast cancer	4.03e-06	8.34e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CPT1A—breast cancer	4.03e-06	8.34e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTR—breast cancer	4.03e-06	8.34e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLG—breast cancer	4e-06	8.27e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HPGDS—breast cancer	3.95e-06	8.18e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT2—breast cancer	3.95e-06	8.18e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—breast cancer	3.95e-06	8.17e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.95e-06	8.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF10—breast cancer	3.93e-06	8.13e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HBA1—breast cancer	3.93e-06	8.13e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—breast cancer	3.9e-06	8.07e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP17A1—breast cancer	3.85e-06	7.97e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—breast cancer	3.84e-06	7.95e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—breast cancer	3.83e-06	7.93e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ACHE—breast cancer	3.83e-06	7.93e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO1—breast cancer	3.81e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS1—breast cancer	3.81e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—breast cancer	3.8e-06	7.86e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFA—breast cancer	3.79e-06	7.85e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—breast cancer	3.79e-06	7.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFBR2—breast cancer	3.74e-06	7.74e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP2D6—breast cancer	3.74e-06	7.73e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—NOS3—breast cancer	3.73e-06	7.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ITPR1—breast cancer	3.68e-06	7.61e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA2—breast cancer	3.67e-06	7.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB4—breast cancer	3.66e-06	7.56e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP3—breast cancer	3.66e-06	7.56e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT5A—breast cancer	3.66e-06	7.56e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	3.65e-06	7.54e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP17A1—breast cancer	3.63e-06	7.51e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS1—breast cancer	3.59e-06	7.43e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO1—breast cancer	3.59e-06	7.43e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.57e-06	7.38e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—FASN—breast cancer	3.56e-06	7.36e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—BCHE—breast cancer	3.54e-06	7.33e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMAD4—breast cancer	3.54e-06	7.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1R—breast cancer	3.52e-06	7.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—CXCL8—breast cancer	3.5e-06	7.25e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC5A5—breast cancer	3.5e-06	7.24e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA2—breast cancer	3.46e-06	7.15e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HES1—breast cancer	3.46e-06	7.15e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—breast cancer	3.44e-06	7.12e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NCOR1—breast cancer	3.44e-06	7.11e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PLA2G4A—breast cancer	3.44e-06	7.11e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTGS2—breast cancer	3.41e-06	7.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CSF2—breast cancer	3.4e-06	7.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF1—breast cancer	3.4e-06	7.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—RAF1—breast cancer	3.39e-06	7.01e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC2A1—breast cancer	3.38e-06	6.99e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NQO1—breast cancer	3.38e-06	6.99e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—breast cancer	3.38e-06	6.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRG1—breast cancer	3.37e-06	6.98e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—FASN—breast cancer	3.35e-06	6.94e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—H2AFX—breast cancer	3.35e-06	6.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—breast cancer	3.35e-06	6.93e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—BCHE—breast cancer	3.34e-06	6.91e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—breast cancer	3.34e-06	6.9e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—E2F1—breast cancer	3.33e-06	6.88e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	3.31e-06	6.85e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC5A5—breast cancer	3.3e-06	6.82e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP3A4—breast cancer	3.3e-06	6.82e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1B1—breast cancer	3.24e-06	6.71e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.22e-06	6.67e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SPP1—breast cancer	3.2e-06	6.61e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NOS3—breast cancer	3.19e-06	6.6e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.19e-06	6.59e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NQO1—breast cancer	3.19e-06	6.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CXCL8—breast cancer	3.18e-06	6.58e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HSP90AA1—breast cancer	3.18e-06	6.58e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB3—breast cancer	3.16e-06	6.54e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR2—breast cancer	3.16e-06	6.53e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP3A4—breast cancer	3.11e-06	6.43e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA1—breast cancer	3.09e-06	6.4e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1B1—breast cancer	3.06e-06	6.32e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP19A1—breast cancer	3.05e-06	6.3e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—STK11—breast cancer	3.05e-06	6.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—breast cancer	3.04e-06	6.29e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—breast cancer	3.03e-06	6.27e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HSP90AA1—breast cancer	3e-06	6.2e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—breast cancer	2.98e-06	6.16e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.95e-06	6.09e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR1—breast cancer	2.94e-06	6.08e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTGS2—breast cancer	2.92e-06	6.04e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA1—breast cancer	2.91e-06	6.03e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HIF1A—breast cancer	2.9e-06	5.99e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—STK11—breast cancer	2.87e-06	5.94e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.87e-06	5.94e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—COMT—breast cancer	2.83e-06	5.86e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LEP—breast cancer	2.83e-06	5.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—breast cancer	2.82e-06	5.83e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CAV1—breast cancer	2.8e-06	5.8e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HMOX1—breast cancer	2.78e-06	5.75e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ITPR1—breast cancer	2.78e-06	5.74e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KDR—breast cancer	2.77e-06	5.73e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—breast cancer	2.7e-06	5.58e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—breast cancer	2.67e-06	5.53e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—COMT—breast cancer	2.67e-06	5.52e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FN1—breast cancer	2.67e-06	5.52e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—breast cancer	2.66e-06	5.5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKBIA—breast cancer	2.64e-06	5.45e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TYMS—breast cancer	2.62e-06	5.42e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HMOX1—breast cancer	2.62e-06	5.42e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ITPR1—breast cancer	2.62e-06	5.41e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH1—breast cancer	2.61e-06	5.4e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOR1—breast cancer	2.59e-06	5.36e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—breast cancer	2.59e-06	5.36e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PLA2G4A—breast cancer	2.59e-06	5.36e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KIT—breast cancer	2.55e-06	5.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—breast cancer	2.55e-06	5.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—APC—breast cancer	2.55e-06	5.28e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—breast cancer	2.55e-06	5.26e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGF—breast cancer	2.52e-06	5.22e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCB1—breast cancer	2.52e-06	5.2e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GPX1—breast cancer	2.48e-06	5.13e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TYMS—breast cancer	2.47e-06	5.11e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYP1A1—breast cancer	2.46e-06	5.08e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—breast cancer	2.44e-06	5.06e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—breast cancer	2.44e-06	5.05e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.44e-06	5.05e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOR1—breast cancer	2.44e-06	5.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ERCC2—breast cancer	2.44e-06	5.04e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—breast cancer	2.4e-06	4.96e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GPX1—breast cancer	2.34e-06	4.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IGF1—breast cancer	2.34e-06	4.83e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT2—breast cancer	2.34e-06	4.83e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—EGFR—breast cancer	2.33e-06	4.81e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.32e-06	4.79e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ERCC2—breast cancer	2.3e-06	4.75e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—breast cancer	2.29e-06	4.74e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—breast cancer	2.24e-06	4.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	2.22e-06	4.6e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SERPINE1—breast cancer	2.22e-06	4.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—breast cancer	2.2e-06	4.54e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—breast cancer	2.18e-06	4.52e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—breast cancer	2.16e-06	4.46e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOS3—breast cancer	2.12e-06	4.38e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CAV1—breast cancer	2.11e-06	4.37e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—breast cancer	2.1e-06	4.34e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	2.02e-06	4.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—breast cancer	2.01e-06	4.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RAF1—breast cancer	2e-06	4.14e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RELA—breast cancer	1.99e-06	4.12e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CAV1—breast cancer	1.99e-06	4.12e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.98e-06	4.1e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.96e-06	4.05e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MTOR—breast cancer	1.96e-06	4.05e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—breast cancer	1.92e-06	3.98e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.88e-06	3.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.87e-06	3.86e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.84e-06	3.8e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.82e-06	3.76e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.81e-06	3.75e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—breast cancer	1.8e-06	3.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—breast cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—breast cancer	1.79e-06	3.7e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—breast cancer	1.75e-06	3.62e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUN—breast cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.73e-06	3.59e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—breast cancer	1.72e-06	3.55e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MMP9—breast cancer	1.7e-06	3.52e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.69e-06	3.5e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—breast cancer	1.69e-06	3.5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—breast cancer	1.69e-06	3.5e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—breast cancer	1.67e-06	3.45e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.65e-06	3.42e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.65e-06	3.41e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NOS3—breast cancer	1.6e-06	3.3e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.59e-06	3.3e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—breast cancer	1.57e-06	3.26e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—breast cancer	1.57e-06	3.24e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.53e-06	3.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—breast cancer	1.51e-06	3.13e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NOS3—breast cancer	1.51e-06	3.11e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—breast cancer	1.47e-06	3.05e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—breast cancer	1.47e-06	3.03e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTGS2—breast cancer	1.46e-06	3.02e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.44e-06	2.99e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—breast cancer	1.4e-06	2.9e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—breast cancer	1.4e-06	2.9e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTGS2—breast cancer	1.38e-06	2.85e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EGFR—breast cancer	1.37e-06	2.84e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—breast cancer	1.3e-06	2.68e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—breast cancer	1.27e-06	2.64e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—breast cancer	1.2e-06	2.48e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.19e-06	2.47e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—breast cancer	1.15e-06	2.39e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—breast cancer	1.1e-06	2.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—breast cancer	1.06e-06	2.18e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—breast cancer	9.74e-07	2.01e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—breast cancer	8.99e-07	1.86e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—breast cancer	8.47e-07	1.75e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—breast cancer	7.34e-07	1.52e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—breast cancer	6.92e-07	1.43e-05	CbGpPWpGaD
